Position in UTHR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,019,182
-$97,992 QoQ
Shares Held
1,881
-0.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#459
of 870 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rossby Financial, LCC holds $1,087,397 across 15 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (93.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,881 | $1,019,182 | |
| 2 | ZTS |
Zoetis Inc.
|
343 | $24,647 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
85 | $14,325 | |
| 4 | HLN |
Haleon plc
|
885 | $8,257 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
222 | $5,463 | |
| 6 | ALKS |
Alkermes plc.
|
64 | $3,353 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
227 | $3,289 | |
| 8 | VTRS |
Viatris Inc
|
206 | $3,271 |
All Filings in UTHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,019,182 | 1,881 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,117,174 | 1,884 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $884,358 | 1,815 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $725,233 | 1,730 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $518,092 | 1,803 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $401,984 | 1,304 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $253,339 | 718 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||